Algeta to host Capital Markets Days

OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --

Intended for US media only Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will host Capital Markets Days this week in Oslo, London and New York. Event summaries and guest speaker details are provided below. Oslo, 18 November 10:00am-2:00pm (CET) KS-Agenda Møtesenter, Haakon VII's gate 9 * Dr Dag Clement Johannessen, Consultant Oncologist, Department of Oncology, University Hospital of Oslo, Norway * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University Hospital, Stockholm, Sweden London, 19 November 10:00am-2:00pm (GMT) Holborn Bars 2(nd) Floor, 138-142 Holborn * Dr E. David Crawford, Professor of Surgery (Urology) & Radiation Oncology, Head Urologic Oncology, University of Colorado, Denver, USA * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University Hospital, Stockholm, Sweden New York, 21 November 12.30pm-4:30pm (EDT) Parker Meridien, 118 West 57(th) Street * Dr Dan George, Director, GU Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA * Dr Neal D. Shore, Director, CPI, Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina, USA The event in New York will be webcast via www.algeta.com, where presentations will also be made available. ### For further information, please contact: Mike Booth +1 646 410 1884 Communications & Corporate Affairs ir@algeta.com Media enquiries: Mark Swallow +44 207 638 9571 Citigate Dewe Rogerson mark.swallow@citigatedr.co.uk Kari Watson +1 781 235 3060 MacDougall Biomedical Communications kwatson@macbiocom.com Investor enquiries: Tricia Truehart +1 646 378 2953 The Trout Group ttruehart@troutgroup.com About Algeta Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com. Press release: http://hugin.info/134655/R/1743766/586643.pdf [HUG#1743766] Source:Algeta ASA